Connection

Elizabeth Garrett-Mayer to HSP40 Heat-Shock Proteins

Back to Details
This is a "connection" page, showing publications Elizabeth Garrett-Mayer has written about HSP40 Heat-Shock Proteins.
Elizabeth Garrett-Mayer
Connection Strength
0.017
HSP40 Heat-Shock Proteins
  1. A phase 2 study of the farnesyltransferase inhibitor tipifarnib in poor-risk and elderly patients with previously untreated acute myelogenous leukemia. Blood. 2007 Feb 15; 109(4):1387-94.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.